FDA Recalls Over 122K Gatorade Cases Over Undeclared Food Dyes
FDA recalls 122,000 Gatorade cases due to undeclared food dyes, affecting 37 states.
2 min read
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for over 122,000 cases of Gatorade distributed across 37 states, citing the presence of undeclared food dyes that may pose a risk to sensitive consumers. The recall was initiated by PepsiCo, the parent company of Gatorade, on September 25th after the discovery of unlisted food colorings Yellow No. 5 and/or Yellow No. 6 in the products.
Recall Details and FDA Classification
Under FDA guidelines, a Class II recall applies to non-compliant products that may cause temporary or medically treatable health issues, with only a low risk of severe health impacts. The affected products include 28-ounce Gatorade bottles in Lemon Lime, Lemon Lime Zero, Orange, and Orange Zero flavors, with a total of 122,021 cases recalled.
The FDA Enforcement Report lists the affected lot numbers, though specific details were not provided in the source material. The recall covers a wide range of states, including 37 in total, though the exact distribution was not specified. PepsiCo has taken responsibility for the recall, and the FDA has issued a warning about the potential risks to sensitive consumers, such as those with allergies or sensitivities to food dyes.
Consumer Impact and Next Steps
Consumers are advised to check for the recalled products and return them to the place of purchase for a full refund. The FDA continues to monitor the situation and may issue further updates as more information becomes available. This recall highlights the importance of food safety regulations and the need for strict adherence to labeling requirements by food manufacturers.
While the FDA has not issued a formal statement on the potential health risks of the undeclared dyes, the recall underscores the agency’s commitment to protecting public health. PepsiCo has not provided additional details on the source of the contamination or the number of affected consumers, but the company has stated that it is working closely with the FDA to address the issue and prevent similar incidents in the future.
Source: OANN
